カテゴリ： Allied Market Research, 世界, 医療/バイオ

手術用接着剤のグローバル市場（2021〜2031）：天然、合成、半合成

■ 英語タイトル：Surgical Glue Market By Product (Natural, Synthetic and Semi Synthetic), By Application (Central Nervous System Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Cosmetic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries, Others), By End user (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23FB241）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23FB241
■ 発行日：2022年10月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：290
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[手術用接着剤のグローバル市場（2021〜2031）：天然、合成、半合成]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本市場調査レポートでは、2021年に2,340.71百万ドルであった世界の手術用接着剤市場規模が、2031年までに4,614.85百万ドルに到達し、2022年から2031年にかけてCAGR（年平均成長率）7.0%で成長すると予測しています。本レポートは、手術用接着剤の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、製品別（天然、合成、半合成）分析、用途別（中枢神経系外科、一般外科、心臓血管外科、整形外科、その他）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、企業状況、企業情報などを掲載しています。また、本レポートは、Baxter International Inc.、B. Braun Melsungen AG、Cohera Medical, Inc.、CryoLife Inc.、CSL Limited、Johnson & Johnson、Ocular Therapeutix Inc.、Sanofi、Sealantis Ltd.、Vivostatなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の手術用接着剤市場規模：製品別
- 天然手術用接着剤の市場規模
- 合成手術用接着剤の市場規模
- 半合成手術用接着剤の市場規模
・世界の手術用接着剤市場規模：用途別
- 中枢神経系外科における市場規模
- 一般外科における市場規模
- 心臓血管外科における市場規模
- 整形外科における市場規模
- その他における市場規模
・世界の手術用接着剤市場規模：エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- その他における市場規模
・世界の手術用接着剤市場規模：地域別
- 北米の手術用接着剤市場規模
- ヨーロッパの手術用接着剤市場規模
- アジア太平洋の手術用接着剤市場規模
- 中南米・中東・アフリカの手術用接着剤市場規模
・企業状況
・企業情報

世界の手術用接着剤市場は、2021年には23億4,071万ドル、2031年には46億1,485万ドルに達すると予測され、2022年から2031年までの年平均成長率は7.0%となる見込みです。

手術用接着剤は、別々のバイアル瓶に入った2つの成分からできています。主にフィブリノゲン、第XIII因子、フィブロネクチンなどの凝固タンパク質の凍結乾燥濃縮物（封止剤）と、凍結乾燥トロンビン（触媒）です。第一の成分は、組織の線溶を阻害するアプロチニン溶液で再構成されます。第二成分（トロンビン）は500I.U.濃度の塩化カルシウムで溶解されます。ヒトフィブリンシーラントの適応は多数あり、あらゆる外科手術に使用されています。また、凝固障害を併発している患者の鼠径ヘルニア修復後の局所出血性合併症の予防にも有効です。

世界の手術用接着剤市場は、高齢者人口の増加、手術件数の増加、創傷や傷害の発生率の増加により、予測期間中に大きな市場成長が見込まれます。さらに、交通事故の増加、手術用接着剤に関する意識の高まり、慢性疾患の有病率の増加が市場成長に大きく寄与しています。しかし、手術用接着剤の高コストと代替製品の入手可能性、低侵襲手術の不人気が市場成長にマイナスの影響を与えています。逆に、新興国における高い成長の可能性は、市場成長のための有利な機会を提供しています。

世界の手術用接着剤市場は、製品、用途、エンドユーザー、地域によって区分されます。製品別では、市場は天然と合成＆半合成に分類されます。用途別では、中枢神経系（CNS）手術、一般手術、心臓血管手術、整形外科手術、美容手術、眼科、泌尿器科、肺外科、その他に分類されます。エンドユーザー別では、病院、外来手術センター、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、欧州のその他地域）、アジア太平洋（中国、日本、オーストラリア、インド、韓国、アジア太平洋のその他地域）、LAMEA（ブラジル、南アフリカ、サウジアラビア、LAMEAのその他地域）に市場を分けて分析しています。

本レポートに掲載されている主要企業には、Artivion, Inc.、B. Braun Melsungen AG、Baxter International Inc.、Becton, Dickinson and Company、Cardinal Health、Integra Lifesciences Corporation、Johnson & Johnson、Medtronic plc、Ocular Therapeutix Inc.、OptMed, Inc.などがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの手術用接着剤市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、一般的な手術用接着剤市場の機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・手術用接着剤市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の手術用接着剤市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
エンドユーザー別
病院
外来手術センター
その他

製品別
天然
合成・半合成

用途別
中枢神経手術
一般手術
心臓血管手術
整形外科手術
美容手術
眼科手術
泌尿器手術
呼吸器手術
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Baxter International Inc.
B. Braun Melsungen AG
Cohera Medical, Inc.
CryoLife Inc.
CSL Limited
Johnson & Johnson
Ocular Therapeutix Inc.
Sanofi
Sealantis Ltd.
Vivostat

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SURGICAL GLUE MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Natural
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Synthetic and Semi Synthetic
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: SURGICAL GLUE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Central Nervous System Surgeries
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 General Surgeries
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Cardiovascular Surgeries
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Orthopedic Surgeries
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
5.6 Cosmetic Surgeries
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market share analysis by country
5.7 Ophthalmic Surgeries
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market share analysis by country
5.8 Urological Surgeries
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market share analysis by country
5.9 Pulmonary Surgeries
5.9.1 Key market trends, growth factors and opportunities
5.9.2 Market size and forecast, by region
5.9.3 Market share analysis by country
6.0 Others
6.0.1 Key market trends, growth factors and opportunities
6.0.2 Market size and forecast, by region
6.0.3 Market share analysis by country
CHAPTER 6: SURGICAL GLUE MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: SURGICAL GLUE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End user
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product
7.2.5.1.3 Market size and forecast, by Application
7.2.5.1.4 Market size and forecast, by End user
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product
7.2.5.2.3 Market size and forecast, by Application
7.2.5.2.4 Market size and forecast, by End user
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product
7.2.5.3.3 Market size and forecast, by Application
7.2.5.3.4 Market size and forecast, by End user
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End user
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product
7.3.5.1.3 Market size and forecast, by Application
7.3.5.1.4 Market size and forecast, by End user
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product
7.3.5.2.3 Market size and forecast, by Application
7.3.5.2.4 Market size and forecast, by End user
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product
7.3.5.3.3 Market size and forecast, by Application
7.3.5.3.4 Market size and forecast, by End user
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product
7.3.5.4.3 Market size and forecast, by Application
7.3.5.4.4 Market size and forecast, by End user
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product
7.3.5.5.3 Market size and forecast, by Application
7.3.5.5.4 Market size and forecast, by End user
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product
7.3.5.6.3 Market size and forecast, by Application
7.3.5.6.4 Market size and forecast, by End user
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End user
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product
7.4.5.1.3 Market size and forecast, by Application
7.4.5.1.4 Market size and forecast, by End user
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product
7.4.5.2.3 Market size and forecast, by Application
7.4.5.2.4 Market size and forecast, by End user
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product
7.4.5.3.3 Market size and forecast, by Application
7.4.5.3.4 Market size and forecast, by End user
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product
7.4.5.4.3 Market size and forecast, by Application
7.4.5.4.4 Market size and forecast, by End user
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product
7.4.5.5.3 Market size and forecast, by Application
7.4.5.5.4 Market size and forecast, by End user
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product
7.4.5.6.3 Market size and forecast, by Application
7.4.5.6.4 Market size and forecast, by End user
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End user
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product
7.5.5.1.3 Market size and forecast, by Application
7.5.5.1.4 Market size and forecast, by End user
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product
7.5.5.2.3 Market size and forecast, by Application
7.5.5.2.4 Market size and forecast, by End user
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product
7.5.5.3.3 Market size and forecast, by Application
7.5.5.3.4 Market size and forecast, by End user
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product
7.5.5.4.3 Market size and forecast, by Application
7.5.5.4.4 Market size and forecast, by End user
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Baxter International Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 B. Braun Melsungen AG
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cohera Medical, Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 CryoLife Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 CSL Limited
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Johnson & Johnson
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Ocular Therapeutix Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Sanofi
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Sealantis Ltd.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Vivostat
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 2. SURGICAL GLUE MARKET FOR NATURAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. SURGICAL GLUE MARKET FOR NATURAL, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. SURGICAL GLUE MARKET FOR SYNTHETIC AND SEMI SYNTHETIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. SURGICAL GLUE MARKET FOR SYNTHETIC AND SEMI SYNTHETIC, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 7. SURGICAL GLUE MARKET FOR CENTRAL NERVOUS SYSTEM SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. SURGICAL GLUE MARKET FOR CENTRAL NERVOUS SYSTEM SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. SURGICAL GLUE MARKET FOR GENERAL SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. SURGICAL GLUE MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. SURGICAL GLUE MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. SURGICAL GLUE MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 13. SURGICAL GLUE MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 14. SURGICAL GLUE MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 15. SURGICAL GLUE MARKET FOR COSMETIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 16. SURGICAL GLUE MARKET FOR COSMETIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 17. SURGICAL GLUE MARKET FOR OPHTHALMIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 18. SURGICAL GLUE MARKET FOR OPHTHALMIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 19. SURGICAL GLUE MARKET FOR UROLOGICAL SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 20. SURGICAL GLUE MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 21. SURGICAL GLUE MARKET FOR PULMONARY SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 22. SURGICAL GLUE MARKET FOR PULMONARY SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 23. SURGICAL GLUE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 24. SURGICAL GLUE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 25. GLOBAL SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. SURGICAL GLUE MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 27. SURGICAL GLUE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 28. SURGICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 29. SURGICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 30. SURGICAL GLUE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 31. SURGICAL GLUE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 32. SURGICAL GLUE MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 33. NORTH AMERICA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 34. NORTH AMERICA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 35. NORTH AMERICA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 36. NORTH AMERICA SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 37. U.S. SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 38. U.S. SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 39. U.S. SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 40. CANADA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 41. CANADA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 42. CANADA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 43. MEXICO SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 44. MEXICO SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 45. MEXICO SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 46. EUROPE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 47. EUROPE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 48. EUROPE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 49. EUROPE SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 50. GERMANY SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 51. GERMANY SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 52. GERMANY SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 53. FRANCE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 54. FRANCE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 55. FRANCE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. UK SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 57. UK SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 58. UK SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 59. ITALY SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 60. ITALY SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 61. ITALY SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 62. SPAIN SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 63. SPAIN SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 64. SPAIN SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 65. REST OF EUROPE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 66. REST OF EUROPE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 67. REST OF EUROPE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 68. ASIA-PACIFIC SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 69. ASIA-PACIFIC SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 70. ASIA-PACIFIC SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 71. ASIA-PACIFIC SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 72. JAPAN SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 73. JAPAN SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 74. JAPAN SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 75. CHINA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 76. CHINA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 77. CHINA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 78. INDIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 79. INDIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 80. INDIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 81. AUSTRALIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 82. AUSTRALIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 83. AUSTRALIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 84. SOUTH KOREA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SOUTH KOREA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SOUTH KOREA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 87. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 88. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 89. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 90. LAMEA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 91. LAMEA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 92. LAMEA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 93. LAMEA SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 94. BRAZIL SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 95. BRAZIL SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 96. BRAZIL SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 97. SAUDI ARABIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 98. SAUDI ARABIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 99. SAUDI ARABIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 100. SOUTH AFRICA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 101. SOUTH AFRICA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 102. SOUTH AFRICA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 103. REST OF LAMEA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 104. REST OF LAMEA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 105. REST OF LAMEA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 106.BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 107.BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
TABLE 108.BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 109.BAXTER INTERNATIONAL INC.: NET SALES
TABLE 110.BAXTER INTERNATIONAL INC.: KEY STRATERGIES
TABLE 111.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 112.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 113.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 114.B. BRAUN MELSUNGEN AG: NET SALES
TABLE 115.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 116.COHERA MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 117.COHERA MEDICAL, INC.: OPERATING SEGMENTS
TABLE 118.COHERA MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 119.COHERA MEDICAL, INC.: NET SALES
TABLE 120.COHERA MEDICAL, INC.: KEY STRATERGIES
TABLE 121.CRYOLIFE INC.: COMPANY SNAPSHOT
TABLE 122.CRYOLIFE INC.: OPERATING SEGMENTS
TABLE 123.CRYOLIFE INC.: PRODUCT PORTFOLIO
TABLE 124.CRYOLIFE INC.: NET SALES
TABLE 125.CRYOLIFE INC.: KEY STRATERGIES
TABLE 126.CSL LIMITED: COMPANY SNAPSHOT
TABLE 127.CSL LIMITED: OPERATING SEGMENTS
TABLE 128.CSL LIMITED: PRODUCT PORTFOLIO
TABLE 129.CSL LIMITED: NET SALES
TABLE 130.CSL LIMITED: KEY STRATERGIES
TABLE 131.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 132.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 133.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 134.JOHNSON & JOHNSON: NET SALES
TABLE 135.JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 136.OCULAR THERAPEUTIX INC.: COMPANY SNAPSHOT
TABLE 137.OCULAR THERAPEUTIX INC.: OPERATING SEGMENTS
TABLE 138.OCULAR THERAPEUTIX INC.: PRODUCT PORTFOLIO
TABLE 139.OCULAR THERAPEUTIX INC.: NET SALES
TABLE 140.OCULAR THERAPEUTIX INC.: KEY STRATERGIES
TABLE 141.SANOFI: COMPANY SNAPSHOT
TABLE 142.SANOFI: OPERATING SEGMENTS
TABLE 143.SANOFI: PRODUCT PORTFOLIO
TABLE 144.SANOFI: NET SALES
TABLE 145.SANOFI: KEY STRATERGIES
TABLE 146.SEALANTIS LTD.: COMPANY SNAPSHOT
TABLE 147.SEALANTIS LTD.: OPERATING SEGMENTS
TABLE 148.SEALANTIS LTD.: PRODUCT PORTFOLIO
TABLE 149.SEALANTIS LTD.: NET SALES
TABLE 150.SEALANTIS LTD.: KEY STRATERGIES
TABLE 151.VIVOSTAT: COMPANY SNAPSHOT
TABLE 152.VIVOSTAT: OPERATING SEGMENTS
TABLE 153.VIVOSTAT: PRODUCT PORTFOLIO
TABLE 154.VIVOSTAT: NET SALES
TABLE 155.VIVOSTAT: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • デジタル式血圧計のグローバル市場（2021〜2031）：腕型、手首型
  • 自家細胞治療のグローバル市場（2021〜2031）：がん、その他
  • PCAポンプのグローバル市場（2021～2031）：電子・無線、機械
  • ビデオ喉頭鏡のグローバル市場（2021〜2031）：固定型、汎用型
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23FB241 )"手術用接着剤のグローバル市場（2021〜2031）：天然、合成、半合成" (英文：Surgical Glue Market By Product (Natural, Synthetic and Semi Synthetic), By Application (Central Nervous System Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Cosmetic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries, Others), By End user (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。